Skip to main content
Top
Published in: World Journal of Surgery 12/2019

Open Access 01-12-2019 | Hypoparathyroidism | Original Scientific Report

Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves’ Disease are Similar to Those After Elective Surgery in Well-Controlled Disease

Authors: Adibah Ali, Miguel Debono, Sabapathy P. Balasubramanian

Published in: World Journal of Surgery | Issue 12/2019

Login to get access

Abstract

Background

Surgery for Graves’ disease (GD) is usually performed after adequate control with medical treatment. Occasionally, rapid pre-operative optimization is required. The primary objective was to compare the outcomes of patients undergoing elective surgery for well-controlled GD with those undergoing rapid pre-operative treatment. We also propose a formal treatment protocol for future use.

Methods

A retrospective cohort study in a tertiary referral centre included 247 patients with well-controlled GD undergoing elective surgery and 19 patients with poorly controlled disease undergoing surgery after rapid optimization. The latter group did not respond well to thionamides (carbimazole and/or propylthiouracil) or had intolerance or side effects to thionamides and were treated with a range of non-thionamide drugs, including Lugol’s iodine, cholestyramine, beta blockers and steroids (with or without thionamides), and closely monitored for 1–2 weeks before surgery. Outcome measures included thyroid storm, hypoparathyroidism and recurrent laryngeal nerve palsy.

Results

In total, 266 patients with male-to-female ratio of 1:6 and median (interquartile range) age of 39 (31–51) were included. Overall, long-term recurrent laryngeal palsy and hypoparathyroidism occurred in 1 (0.38%) and 13 (4.9%) patients, respectively. No patient had thyroid storm. There was no significant difference in hypoparathyroidism (p = 1), vocal cord palsy (p = 0.803) and post-operative bleeding (p = 0.362), between elective surgery and rapid optimization groups.

Conclusion

Rapid pre-operative treatment is effective, safe and is associated with similar outcomes compared to usual treatment. A rapid pre-operative optimization protocol is proposed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358:2594–2605CrossRef Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358:2594–2605CrossRef
2.
go back to reference Hussain YS, Hookham JC, Allahabadia A et al (2017) Epidemiology, management and outcomes of Graves’ disease-real life data. Endocrine 56:568–578CrossRef Hussain YS, Hookham JC, Allahabadia A et al (2017) Epidemiology, management and outcomes of Graves’ disease-real life data. Endocrine 56:568–578CrossRef
3.
go back to reference Abraham P, Avenell A, McGeoch SC et al (2010) Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database Syst Rev 1:CD003420 Abraham P, Avenell A, McGeoch SC et al (2010) Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database Syst Rev 1:CD003420
4.
go back to reference Girgis CM, Champion BL, Wall JR (2011) Current concepts in graves’ disease. Ther Adv Endocrinol Metab 2:135–144CrossRef Girgis CM, Champion BL, Wall JR (2011) Current concepts in graves’ disease. Ther Adv Endocrinol Metab 2:135–144CrossRef
5.
go back to reference Zambudio AR, Rodriguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25CrossRef Zambudio AR, Rodriguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25CrossRef
6.
go back to reference Langley RW, Burch HB (2003) Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin North Am 32:519–534CrossRef Langley RW, Burch HB (2003) Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin North Am 32:519–534CrossRef
7.
go back to reference Berghout A, Wiersinga WM, Brummelkamp WH (1989) Sodium ipodate in the preparation of Graves’ hyperthyroid patients for thyroidectomy. Horm Res 31:256–260CrossRef Berghout A, Wiersinga WM, Brummelkamp WH (1989) Sodium ipodate in the preparation of Graves’ hyperthyroid patients for thyroidectomy. Horm Res 31:256–260CrossRef
8.
go back to reference Bogazzi F, Miccoli P, Berti P et al (2002) Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114–1117 (discussion 1118) CrossRef Bogazzi F, Miccoli P, Berti P et al (2002) Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114–1117 (discussion 1118) CrossRef
9.
go back to reference Baeza A, Aguayo J, Barria M et al (1991) Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol 35:439–442CrossRef Baeza A, Aguayo J, Barria M et al (1991) Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol 35:439–442CrossRef
10.
go back to reference Panzer C, Beazley R, Braverman L (2004) Rapid preoperative preparation for severe hyperthyroid Graves’ disease. J Clin Endocrinol Metab 89:2142–2144CrossRef Panzer C, Beazley R, Braverman L (2004) Rapid preoperative preparation for severe hyperthyroid Graves’ disease. J Clin Endocrinol Metab 89:2142–2144CrossRef
11.
go back to reference Fischli S, Lucchini B, Muller W et al (2016) Rapid preoperative blockage of thyroid hormone production/secretion in patients with Graves’ disease. Swiss Med Wkly 146:w14243PubMed Fischli S, Lucchini B, Muller W et al (2016) Rapid preoperative blockage of thyroid hormone production/secretion in patients with Graves’ disease. Swiss Med Wkly 146:w14243PubMed
12.
go back to reference Rubio GA, Koru-Sengul T, Vaghaiwalla TM et al (2017) Postoperative outcomes in Graves’ Disease patients: results from the nationwide inpatient sample database. Thyroid 27:825–831CrossRef Rubio GA, Koru-Sengul T, Vaghaiwalla TM et al (2017) Postoperative outcomes in Graves’ Disease patients: results from the nationwide inpatient sample database. Thyroid 27:825–831CrossRef
13.
go back to reference Pesce CE, Shiue Z, Tsai HL et al (2010) Postoperative hypocalcemia after thyroidectomy for Graves’ disease. Thyroid 20:1279–1283CrossRef Pesce CE, Shiue Z, Tsai HL et al (2010) Postoperative hypocalcemia after thyroidectomy for Graves’ disease. Thyroid 20:1279–1283CrossRef
14.
go back to reference Chiang FY, Lin JC, Wu CW et al (2006) Morbidity after total thyroidectomy for benign thyroid disease: comparison of Graves’ disease and non-Graves’ disease. Kaohsiung J Med Sci 22:554–559CrossRef Chiang FY, Lin JC, Wu CW et al (2006) Morbidity after total thyroidectomy for benign thyroid disease: comparison of Graves’ disease and non-Graves’ disease. Kaohsiung J Med Sci 22:554–559CrossRef
15.
go back to reference Hassan I, Danila R, Aljabri H et al (2008) Is rapid preparation for thyroidectomy in severe Graves’ disease beneficial? The relationship between clinical and immunohistochemical aspects. Endocrine 33:189–195CrossRef Hassan I, Danila R, Aljabri H et al (2008) Is rapid preparation for thyroidectomy in severe Graves’ disease beneficial? The relationship between clinical and immunohistochemical aspects. Endocrine 33:189–195CrossRef
16.
go back to reference Yamashita H, Murakami T, Noguchi S et al (1999) Postoperative tetany in Graves disease: important role of vitamin D metabolites. Ann Surg 229:237–245CrossRef Yamashita H, Murakami T, Noguchi S et al (1999) Postoperative tetany in Graves disease: important role of vitamin D metabolites. Ann Surg 229:237–245CrossRef
17.
go back to reference Stedman T, Chew P, Truran P et al (2017) Modification, validation and implementation of a protocol for post-thyroidectomy hypocalcaemia. Ann R Coll Surg Engl 100:1–5 Stedman T, Chew P, Truran P et al (2017) Modification, validation and implementation of a protocol for post-thyroidectomy hypocalcaemia. Ann R Coll Surg Engl 100:1–5
18.
19.
go back to reference Glinoer D, Hesch D, Lagasse R et al (1987) The management of hyperthyroidism due to Graves’ disease in Europe in 1986. Results of an international survey. Acta Endocrinol Suppl (Copenh) 285:3–23 Glinoer D, Hesch D, Lagasse R et al (1987) The management of hyperthyroidism due to Graves’ disease in Europe in 1986. Results of an international survey. Acta Endocrinol Suppl (Copenh) 285:3–23
20.
go back to reference Patwardhan NA, Moront M, Rao S et al (1993) Surgery still has a role in Graves’ hyperthyroidism. Surgery 114:1108–1112 (discussion 1112-1103) PubMed Patwardhan NA, Moront M, Rao S et al (1993) Surgery still has a role in Graves’ hyperthyroidism. Surgery 114:1108–1112 (discussion 1112-1103) PubMed
21.
go back to reference Hookham J, Collins EE, Allahabadia A et al (2017) Variation in the use of definitive treatment options in the management of Graves’ disease: a UK clinician survey. Postgrad Med J 93:198–204CrossRef Hookham J, Collins EE, Allahabadia A et al (2017) Variation in the use of definitive treatment options in the management of Graves’ disease: a UK clinician survey. Postgrad Med J 93:198–204CrossRef
23.
go back to reference Ross DS, Burch HB, Cooper DS et al (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343–1421CrossRef Ross DS, Burch HB, Cooper DS et al (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343–1421CrossRef
24.
go back to reference Palit TK, Miller CC 3rd, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves’ disease: a meta-analysis. J Surg Res 90:161–165CrossRef Palit TK, Miller CC 3rd, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves’ disease: a meta-analysis. J Surg Res 90:161–165CrossRef
25.
go back to reference Hookham J, Truran P, Allahabadia A et al (2017) Patients’ perceptions and views of surgery and radioiodine ablation in the definitive management of Graves’ disease. Postgrad Med J 93:266–270CrossRef Hookham J, Truran P, Allahabadia A et al (2017) Patients’ perceptions and views of surgery and radioiodine ablation in the definitive management of Graves’ disease. Postgrad Med J 93:266–270CrossRef
26.
go back to reference Gorman CA (1995) Therapeutic controversies. Radioiodine therapy does not aggravate Graves’ ophthalmopathy. J Clin Endocrinol Metab 80:340–342CrossRef Gorman CA (1995) Therapeutic controversies. Radioiodine therapy does not aggravate Graves’ ophthalmopathy. J Clin Endocrinol Metab 80:340–342CrossRef
27.
go back to reference Tallstedt L, Lundell G, Torring O et al (1992) Occurrence of ophthalmopathy after treatment for Graves’ hyperthyroidism. The Thyroid Study Group. N Engl J Med 326:1733–1738CrossRef Tallstedt L, Lundell G, Torring O et al (1992) Occurrence of ophthalmopathy after treatment for Graves’ hyperthyroidism. The Thyroid Study Group. N Engl J Med 326:1733–1738CrossRef
28.
go back to reference Shinall MC Jr, Broome JT, Nookala R et al (2013) Total thyroidectomy for Graves’ disease: compliance with American Thyroid Association guidelines may not always be necessary. Surgery 154:1009–1015CrossRef Shinall MC Jr, Broome JT, Nookala R et al (2013) Total thyroidectomy for Graves’ disease: compliance with American Thyroid Association guidelines may not always be necessary. Surgery 154:1009–1015CrossRef
29.
go back to reference Al Jassim A, Wallace T, Bouhabel S et al (2018) A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery? J Otolaryngol Head Neck Surg 47:37CrossRef Al Jassim A, Wallace T, Bouhabel S et al (2018) A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery? J Otolaryngol Head Neck Surg 47:37CrossRef
30.
go back to reference Nair GC, Balu MJC, Menon R et al (2018) Preoperative preparation of hyperthyroidism for thyroidectomy—role of supersaturated iodine and lithium carbonate. Indian J Endocrinol Metab 22:392–396CrossRef Nair GC, Balu MJC, Menon R et al (2018) Preoperative preparation of hyperthyroidism for thyroidectomy—role of supersaturated iodine and lithium carbonate. Indian J Endocrinol Metab 22:392–396CrossRef
31.
go back to reference Simsir IY, Ozdemir M, Duman S et al (2018) Therapeutic plasmapheresis in thyrotoxic patients. Endocrine 62:144–148CrossRef Simsir IY, Ozdemir M, Duman S et al (2018) Therapeutic plasmapheresis in thyrotoxic patients. Endocrine 62:144–148CrossRef
Metadata
Title
Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves’ Disease are Similar to Those After Elective Surgery in Well-Controlled Disease
Authors
Adibah Ali
Miguel Debono
Sabapathy P. Balasubramanian
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 12/2019
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05125-5

Other articles of this Issue 12/2019

World Journal of Surgery 12/2019 Go to the issue